Increase of knowledge in clinical implications of CMV and treatment strategies in CMV+ allo HSCT recipients 

Topics: 

• CMV risk factors for CMV infection and disease in HSCT patients (lack of CMV T-cell immunity)
• CMV diagnostics (Viral load, how to measure, how to monitor, resistance)
• CMV infection and disease in HSCT
  • Risk minimalisation strategies
• Post-transplant complications
• CMV viremia and post-HSCT mortality
• Treatment strategies CMV
  • Pre-emptive treatment
  • Prophylaxis
• Conclusions

Language: English